Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 14, 2019
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial
Geraldine Blanchard Rohner, Olga Chatzis, Pailinrut Chinwangso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2014
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
Anna Guidetti, Carmelo Carlo-Stella, Silvia L Locatelli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 13, 2024
Safety, reactogenicity, and immunogenicity of ZR-202-CoV and ZR-202a-CoV recombinant vaccines compared with Comirnaty<sup>Ⓡ</sup>: A randomized, observer-blind, controlled, phase 1 study
Samba O Sow, Milagritos D Tapia, Fadima C Haidara, et al.
British Journal of Haematology
|
September 22, 2016
Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma
Scott D Ramsey, Auayporn Nademanee, Tamas Masszi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2013
Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM
Liliana Devizzi, Anna Guidetti, Ettore Seregni, et al.
Eclinicalmedicine
|
August 13, 2021
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP<sub>gen</sub> or combined TdaP<sub>gen</sub> vaccines
Punnee Pitisuttithum, Jittima Dhitavat, Chukiat Sirivichayakul, et al.
Blood Cancer Journal
|
October 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials
Simonetta Viviani, Chiara Pavoni, Sally F Barrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome
George Z Rassidakis, L Jeffrey Medeiros, Timothy J McDonnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome
Marco Herling, George Z Rassidakis, L Jeffrey Medeiros, et al.
Human Vaccines & Immunotherapeutics
|
July 4, 2023
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
Samba O Sow, Milagritos D Tapia, Fadima Cheick Haidara, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 14, 2019
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial
Geraldine Blanchard Rohner, Olga Chatzis, Pailinrut Chinwangso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2014
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
Anna Guidetti, Carmelo Carlo-Stella, Silvia L Locatelli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 13, 2024
Safety, reactogenicity, and immunogenicity of ZR-202-CoV and ZR-202a-CoV recombinant vaccines compared with Comirnaty<sup>Ⓡ</sup>: A randomized, observer-blind, controlled, phase 1 study
Samba O Sow, Milagritos D Tapia, Fadima C Haidara, et al.
British Journal of Haematology
|
September 22, 2016
Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma
Scott D Ramsey, Auayporn Nademanee, Tamas Masszi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2013
Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM
Liliana Devizzi, Anna Guidetti, Ettore Seregni, et al.
Eclinicalmedicine
|
August 13, 2021
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP<sub>gen</sub> or combined TdaP<sub>gen</sub> vaccines
Punnee Pitisuttithum, Jittima Dhitavat, Chukiat Sirivichayakul, et al.
Blood Cancer Journal
|
October 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials
Simonetta Viviani, Chiara Pavoni, Sally F Barrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome
George Z Rassidakis, L Jeffrey Medeiros, Timothy J McDonnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome
Marco Herling, George Z Rassidakis, L Jeffrey Medeiros, et al.
Human Vaccines & Immunotherapeutics
|
July 4, 2023
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
Samba O Sow, Milagritos D Tapia, Fadima Cheick Haidara, et al.
Page
of 12